BIOCON.NS
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
3 more panels on BIOCON.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $167.80B | $150.52B | $141.96B | $109.34B | +11.5% |
| Operating revenue | $167.80B | $150.52B | $141.96B | $109.34B | +11.5% |
| Cost of revenue | $56.95B | $51.98B | $49.07B | $36.67B | +9.6% |
| Gross profit | $110.85B | $98.54B | $92.89B | $72.67B | +12.5% |
| Research & development | $7.08B | $6.34B | $7.12B | $4.90B | +11.7% |
| Selling, general & admin | $13.73B | $12.72B | $8.86B | $4.87B | +8.0% |
| Total operating expense | $93.63B | $82.28B | $78.55B | $56.40B | +13.8% |
| Operating income | $17.22B | $16.26B | $14.35B | $16.27B | +5.9% |
| Net interest income | -$8.75B | -$7.89B | -$8.13B | -$3.07B | -10.9% |
| Pre-tax income | $4.48B | $18.87B | $15.25B | $8.97B | -76.3% |
| Tax provision | $791.00M | $4.57B | $2.27B | $2.54B | -82.7% |
| Net income | $3.86B | $10.13B | $10.22B | $4.63B | -61.9% |
| Net income to common | $3.86B | $10.13B | $10.22B | $4.63B | -61.9% |
| Basic EPS | 2.82 | 8.46 | 8.55 | 3.88 | -66.7% |
| Diluted EPS | 2.82 | 8.46 | 8.54 | 3.87 | -66.7% |
| EBIT | $14.13B | $27.74B | $25.00B | $13.16B | -49.1% |
| EBITDA | $33.69B | $44.61B | $40.68B | $24.29B | -24.5% |
| Basic shares | 1.37B | 1.20B | 1.20B | 1.19B | +14.1% |
| Diluted shares | 1.37B | 1.20B | 1.20B | 1.20B | +14.2% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $24.16B | $32.27B | $12.33B | $13.23B | -25.1% |
| Cash & short-term investments | $40.43B | $49.24B | $31.12B | $37.26B | -17.9% |
| Accounts receivable | $59.87B | $54.88B | $62.31B | $35.73B | +9.1% |
| Inventory | $60.86B | $49.31B | $49.44B | $42.44B | +23.4% |
| Total current assets | $171.80B | $162.86B | $151.79B | $123.34B | +5.5% |
| Property, plant & equipment | $147.34B | $136.08B | $122.08B | $101.23B | +8.3% |
| Goodwill & intangibles | $288.09B | $270.58B | $266.59B | $266.62B | +6.5% |
| Total assets | $636.51B | $587.97B | $560.71B | $520.43B | +8.3% |
| Total current liabilities | $140.69B | $143.34B | $153.59B | $85.11B | -1.8% |
| Current debt | $40.78B | $53.50B | $27.97B | $24.80B | -23.8% |
| Long-term debt | $107.46B | $124.05B | $129.32B | $152.91B | -13.4% |
| Total debt | $154.34B | $183.62B | $162.77B | $180.19B | -15.9% |
| Total liabilities | $270.29B | $310.85B | $307.96B | $295.54B | -13.0% |
| Retained earnings | $139.92B | $189.59B | $176.03B | $160.86B | -26.2% |
| Shareholder equity | $340.32B | $216.44B | $197.84B | $178.67B | +57.2% |
| Working capital | $31.11B | $19.52B | -$1.80B | $38.23B | +59.3% |
| Net tangible assets | $52.23B | -$54.14B | -$68.75B | -$87.95B | +196.5% |
| Shares issued | 1.62B | 1.20B | 1.20B | 1.20B | +35.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $3.69B | $14.29B | $12.98B | $6.43B | -74.2% |
| Depreciation & amortisation | $19.57B | $16.87B | $15.69B | $11.13B | +16.0% |
| Stock-based compensation | $1.64B | $1.37B | $1.01B | $1.38B | +19.6% |
| Change in working capital | -$11.32B | $9.23B | -$6.35B | -$5.01B | -222.7% |
| Operating cash flow | $19.94B | $40.61B | $29.54B | $18.52B | -50.9% |
| Capital expenditure | -$19.12B | -$23.43B | -$19.32B | -$17.26B | +18.4% |
| Investing cash flow | -$20.82B | -$2.34B | -$10.04B | -$142.82B | -789.4% |
| Share buybacks | -$26.00M | $0 | $0 | -$647.00M | — |
| Dividends paid | -$908.00M | -$829.00M | -$2.03B | -$718.00M | -9.5% |
| Financing cash flow | -$9.24B | -$18.54B | -$23.33B | $130.49B | +50.2% |
| Free cash flow | $823.00M | $17.18B | $10.22B | $1.26B | -95.2% |
| End cash position | $21.11B | $29.24B | $9.20B | $12.95B | -27.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $42.92B | $44.84B | $41.73B | $42.63B | $39.10B | — | -4.3% |
| Operating revenue | $42.92B | $44.84B | $41.73B | $42.63B | $39.10B | — | -4.3% |
| Cost of revenue | $14.68B | $13.99B | $13.39B | $15.47B | $14.05B | — | +4.9% |
| Gross profit | $28.24B | — | — | — | — | $24.62B | — |
| Research & development | -$16.00M | -$128.00M | -$531.00M | -$132.00M | -$346.00M | — | +87.5% |
| Total operating expense | $25.24B | $25.78B | $25.16B | $23.53B | $21.94B | — | -2.1% |
| Operating income | $3.00B | $5.07B | $3.18B | $3.62B | $3.11B | — | -40.9% |
| Net interest income | -$2.13B | -$2.31B | -$2.10B | -$2.72B | -$2.77B | — | +7.9% |
| Pre-tax income | $1.28B | $2.48B | -$678.00M | $1.71B | $969.00M | — | -48.4% |
| Tax provision | -$92.00M | $489.00M | -$160.00M | $385.00M | $77.00M | — | -118.8% |
| Net income | $1.41B | $1.26B | $1.44B | $845.00M | $314.00M | — | +12.1% |
| Net income to common | $1.41B | $1.26B | $1.44B | $845.00M | $314.00M | — | +12.1% |
| Basic EPS | 0.87 | 0.79 | 1.08 | 0.66 | 0.26 | — | +10.1% |
| Diluted EPS | 0.87 | 0.79 | 1.07 | 0.65 | 0.26 | — | +10.1% |
| EBIT | $3.41B | $4.79B | $1.42B | $4.43B | $3.74B | — | -28.9% |
| EBITDA | $8.88B | $9.92B | $6.57B | $9.16B | $8.29B | — | -10.5% |
| Basic shares | 1.62B | 1.59B | 1.33B | 1.28B | 1.21B | — | +1.8% |
| Diluted shares | 1.62B | 1.59B | 1.34B | 1.30B | 1.21B | — | +1.8% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $24.16B | $42.75B | $32.27B | -43.5% |
| Cash & short-term investments | $40.43B | $64.69B | $49.24B | -37.5% |
| Accounts receivable | $59.87B | $55.19B | $54.88B | +8.5% |
| Inventory | $60.86B | $57.77B | $49.31B | +5.3% |
| Total current assets | $171.80B | $187.81B | $162.86B | -8.5% |
| Property, plant & equipment | $147.34B | $141.27B | $136.08B | +4.3% |
| Goodwill & intangibles | $288.09B | $277.87B | $270.58B | +3.7% |
| Total assets | $636.51B | $627.60B | $587.97B | +1.4% |
| Total current liabilities | $140.69B | $162.54B | $143.34B | -13.4% |
| Current debt | $40.78B | $53.38B | $53.50B | -23.6% |
| Long-term debt | $107.46B | $105.70B | $124.05B | +1.7% |
| Total debt | $154.34B | $165.35B | $183.62B | -6.7% |
| Total liabilities | $270.29B | $297.05B | $310.85B | -9.0% |
| Retained earnings | $139.92B | — | $189.59B | — |
| Shareholder equity | $340.32B | $268.04B | $216.44B | +27.0% |
| Working capital | $31.11B | $25.27B | $19.52B | +23.1% |
| Net tangible assets | $52.23B | -$9.83B | -$54.14B | +631.4% |
| Shares issued | 1.62B | 1.34B | 1.20B | +21.2% |
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.